Miniatura

Fitxers

Bullon-VelaV.pdf (434.84 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2020-10-01

Llicència de publicació

cc by-nc (c) Bullon Vela, Vanessa et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173975

Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1177/2042018820958298

Resum

Background: Visceral adipose tissue (VAT) has a hazardous influence on systemic inflammation, insulin resistance and an adverse metabolic profile, which increases the risk of developing non-alcoholic fatty liver disease (NAFLD) and chronic complications of diabetes. In our study we aimed to evaluate the association of VAT and the triglyceride glucose (TyG) as a proxy of insulin resistance surrogated with metabolic and liver risk factors among subjects diagnosed with metabolic syndrome (MetS). Methods: A cross-sectional study was performed including 326 participants with MetS (55-75 years) from the PREDIMED-Plus study. Liver-status markers, VAT and TyG were assessed. Participants were stratified by tertiles according to VAT (n = 254) and TyG (n = 326). A receiver operating characteristic curve was used to analyse the efficiency of TyG for VAT. Results: Subjects with greater visceral fat depots showed worse lipid profile, higher homeostatic model assessment for insulin resistance (HOMA-IR), TyG, alanine transaminase (ALT), fibroblast growth factor-21 (FGF-21), fatty liver index (FLI) and hepatic steatosis index (HSI) compared with participants in the first tertile. The multi-adjusted linear-regression analyses indicated that individuals in the third tertile of TyG (>9.1-10.7) had a positive association with HOMA-IR [beta = 3.07 (95% confidence interval (CI) 2.28-3.86; p trend < 0.001)], ALT [beta = 7.43 (95% CI 2.23-12.63; p trend = 0.005)], gamma glutamyl transferase (GGT) [beta = 14.12 (95% CI 3.64-24.61; p trend = 0.008)], FGF-21 [beta = 190.69 (95% CI 93.13-288.25; p trend < 0.001)], FLI [beta = 18.65 (95% CI 14.97-22.23; p trend < 0.001)] and HSI [beta = 3.46 (95% CI, 2.23-4.68; p trend < 0.001)] versus participants from the first tertile. Interestingly, the TyG showed the largest area under the receiver operating curve (AUC) for women (AUC = 0.713; 95% CI 0.62-0.79) compared with men (AUC = 0.570; 95% CI 0.48-0.66). Conclusions: A disrupted VAT enlargement and impairment of TyG are strongly associated with liver status and cardiometabolic risk factors linked with NAFLD in individuals diagnosed with MetS. Moreover, the TyG could be used as a suitable and reliable marker estimator of VAT.

Matèries

Resistència a la insulina, Síndrome metabòlica, Malalties del fetge

Matèries (anglès)

Insulin resistance, Metabolic syndrome, Liver diseases

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

BULLÓN VELA, Vanessa, ABETE, Itziar, TUR, Josep antoni, KONIECZNA, Jadwiga, ROMAGUERA, Dora, PINTO, Xavier, CORBELLA, Emili, MARTÍNEZ-GONZÁLEZ, Miguel ángel, SAYÓN OREA, Carmen, TOLEDO ATUCHA, Estefanía, CORELLA PIQUER, Dolores, MACÍAS GONZÁLEZ, Manuel, TINAHONES, Francisco j., FITÓ COLOMER, Montserrat, ESTRUCH RIBA, Ramon, ROS RAHOLA, Emilio, SALAS SALVADÓ, Jordi, DAIMIEL, Lidia, MASCARÓ, Catalina m., ZULET, M. angeles, MARTÍNEZ, J. alfredo. Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications. _Therapeutic Advances In Endocrinology And Metabolism_. 2020. Vol. 11 p. [consulta: 20 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/173975]

Exportar metadades

JSON - METS

Compartir registre